Clinical Trials in Los Angeles

Showing 13501-13520 of 16,901 trials

AqueSys Microfistula Implant in Refractory Glaucoma

NCT01640756

To establish the safety and performance of the AqueSys Microfistula Implant in eyes with refractory glaucoma.

AqueSys, Inc.60 participantsStarted Jul 2012

Fayetteville, Arkansas, United States • Los Angeles, California, United States • San Diego, California, United States +11 more locations

COMPLETEDPhase 2< 1 mile

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

NCT00774852

This study is for individuals with lupus who have developed complications in their kidneys, or lupus nephritis. The study will determine whether adding the experimental medication abatacept to standard cyclophosphamide therapy is more effective in improving lupus nephritis than standard cyclophosphamide therapy by itself.

Lupus NephritisLupus Erythematosus, Systemic

National Institute of Allergy and Infectious Diseases (NIAID)137 participantsStarted Nov 2008

Birmingham, Alabama, United States • La Jolla, California, United States • Los Angeles, California, United States +20 more locations

AqueSys Microfistula Implant in Refractory Glaucoma

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

Find Trials by Condition in Los Angeles

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults

Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2

A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence

NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses